Zilovertamab vedotin, an antibody drug conjugate (ADC) developed by Merck & Co (MSD) to treat diffuse large B-cell lymphoma ...

Daiichi Sankyo and MSD have voluntarily withdrawn the biologics licence application (BLA) in the US for their HER3-directed ...

For the new graduates at the Maryland School for the Deaf, Friday’s commencement ceremony was the culmination of a year of big plans and accomplishments. The school’s theme for the past year was ...

Louisville MSD customers in Jefferson and Oldham counties could see higher prices starting in Summer 2025. The MSD board ...

The Louisville MSD Board approved a preliminary rate increase Tuesday, saying it's going to protect public health, property ...

A year ago, MSD and Daiichi Sankyo's HER3-targeting antibody-drug conjugate patritumab deruxtecan (HER3-DXd) was rejected by ...

Daiichi Sankyo and MSD have announced the first subject dosing in the Phase III Ideate-Esophageal01 trial, assessing the ...

He’s been putting more of his paycheck toward paying his MSD bill for the last 20 years. “They increase it every year it seems like,” Fawbush said. The company has raised rates every year since 2005.

Louisville MSD board members voted to approve a preliminary rate increase. If approved, the rate increase would add $3.91 to the average monthly bill for customers in Jefferson County and $1.57 ...